Subsidiary products of Shinva Medical Instrument (600587.SH) obtained second class medical equipment registration certificate.
Xinhua Medical (600587.SH) announced that its subsidiary Shandong Xinhua Medical Environmental Protection Equipment Co., Ltd. recently received the "Medical Device Registration Certificate of the People's Republic of China" issued by the Shandong Province Drug Administration. The product name is: Medical Central Suction System, which is used to provide negative pressure and generate suction to the operating room, emergency room, treatment room, and ward terminals in hospitals.
Shinva Medical Instrument (600587.SH) announced that its subsidiary, Shandong Xinhua Medical Environmental Equipment Co., Ltd., has recently received the "Medical Device Registration Certificate of the People's Republic of China" issued by the Shandong Provincial Drug Administration. The product name is Medical Center Suction System, which is used to provide negative pressure to operating rooms, emergency rooms, treatment rooms, and ward terminals in hospitals to generate suction.
The acquisition of the Medical Center Suction System registration certificate enables the company to upgrade to a comprehensive solution provider in the field of medical gas engineering, including "core equipment + engineering installation + after-sales service". This can synergize with existing product lines and effectively enhance the company's overall competitiveness in the field of medical gas.
Related Articles

Ningbo Jintian Copper (Group) (601609.SH) plans to establish a company to invest in and build a copper strip production base in Vietnam.

CR ASIA(00831) grants 16.8 million share purchase rights.
WEIGAO GROUP (01066) spent 6.3881 million Hong Kong dollars to repurchase 1.6736 million shares on March 31st.
Ningbo Jintian Copper (Group) (601609.SH) plans to establish a company to invest in and build a copper strip production base in Vietnam.

CR ASIA(00831) grants 16.8 million share purchase rights.

WEIGAO GROUP (01066) spent 6.3881 million Hong Kong dollars to repurchase 1.6736 million shares on March 31st.
RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


